Beating Hep C in Inner-City Baltimore

Share

Almost all of a large group of inner-city Baltimore individuals coinfected with HIV and hepatitis C virus (HCV) were recently cured of hep C at Johns Hopkins University School of Medicine, showing the potential for successful treatment in a traditionally challenging group of people.

Researchers studied 2014 to 2016 data on 255 HIV/HCV-coinfected individuals enrolled in studies of HIV or HIV/HCV coinfection at the university.

Seventy-three percent of the study group were men, and 88 percent were Black. Fifty-seven percent had a psychiatric condition, and 73 percent had a history of illicit drug use. Ninety-seven percent were taking antiretroviral (ARV) treatment for HIV.

A total of 96.5 percent of the overall group was cured of hep C. The cure rate was 98 percent among those with an undetectable HIV viral load, compared with 88 percent of those with a detectable HIV viral load.

“The model of care we describe in our manuscript would be easy to replicate in other HIV care settings,” says Oluwaseun Falade-Nwulia MBBS, MPH, an assistant professor of infectious diseases at Johns Hopkins and the study’s lead author. “The hope is that data such as ours provide additional impetus to expand access to hepatitis C treatment

POZ Personals

POZ on Facebook

POZ on Twitter

Social Media

Related Sites

Newsletter subscription

Thank you! Please watch for an email from us to confirm your subscription.

Please enter a valid email address.

The Captcha is required.

Please select Newsletter option.

Enter Email Address

POZ Email Update

Twice weekly HIV/AIDS news updates

POZ Treatment Email Update

Latest HIV/AIDS treatment info sent weekly

Hep Email Update

Latest hepatitis news sent weekly

POZ Job Posting Alert

Sent whenever new job openings are added

Our site is able to provide content to you for free but we are able to do this by displaying advertisements. We strive to be ethical in our use of ads. Please add our domain to your ad blocker's whitelist.